American Society of Hematology

Schedule and Program

The following programing corresponds to the 2019 Highlights of ASH in Latin America.

8:00 a.m.
Registration and Exhibition Opens
8:15 a.m.
Welcome and Introductions
8:30 a.m.
Acute Myeloid Leukemia
James Foran, MD, Mayo Clinic Florida
9:00 a.m.
Acute Lymphoblastic Leukemia
Michaela Liedtke, MD, Stanford University
9:30 a.m.
Myelodysplastic Syndromes
Mikkael Sekeres, MD, Cleveland Clinic
10:00 a.m.
Panel Discussion
10:30 a.m.
Coffee Break and Exhibition
11:00 a.m.
Non-Hodgkin Lymphoma
John Sweetenham, MD, Huntsman Cancer Institute at the University of Utah
11:30 a.m.
Hodgkin Lymphoma
Catherine Diefenbach, MD, New York University
12:00 p.m.
Panel Discussion
12:30 p.m.
Lunch with the Experts Session
General Lunch in Exhibit Hall
1:45 p.m.
Chronic Lymphocytic Leukemia
Nitin Jain, MD Anderson Cancer Center
2:15 p.m.
Myeloproliferative Neoplasms including Chronic Myeloid Leukemia
Ann Mullally, MD, Brigham and Women’s Hospital
2:45 p.m.
Myeloma & Plasma Cell Dyscrasia
Jeffrey Zonder, MD, Karmanos Cancer Institute
3:15 p.m.
Panel Discussion
3:45 p.m.
Coffee Break and Exhibition
4:15 p.m.
Venous Thromboembolism
Roy Silverstein MD, Medical College of Wisconsin
4:45 p.m.
Special Session on ASH Clinical Practice Guidelines on VTE for Latin America
Ignacio Neumann, MD, PhD, Panel Facilitator and Lead Methodologist

Suely Rezende, MD, Panel Member and VTE Medical Chapter Member
5:30 p.m.
Panel Discussion
6:00 p.m.
Closing Remarks
7:30 a.m.
Highlights of ASH Breakfast Session (ends at 8:30 a.m.)
8:00 a.m.
Registration and Exhibition
8:30 a.m.
Welcome and Recognition of Highlights of ASH Partner Organizations
8:45 a.m.
2018 ASH Annual Meeting: Best of ASH Summary
Mark Udden, MD, Baylor University
9:15 a.m.
Bone Marrow Transplant
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center
9:45 a.m.
Panel Discussion
10:15 a.m.
Coffee Break and Exhibition
10:45 a.m.
Aplastic Anemia/Bone Marrow Failure
Phillip Scheinberg, MD, Hospital Sao Jose
11:15 a.m.
Red Cell Disorders: Including disorders of Iron and Hemolysis
Marc J. Kahn, MD, MBA, Tulane University
11:45 a.m.
Panel Discussion
12:15 p.m.
Lunch with the Experts Session
General Lunch in Exhibit Hall
1:30 p.m.
Martha Mims, MD, Baylor University
2:00 p.m.
Transfusion Medicine and Pheresis
Michael Linenberger, MD, University of Washington
2:30 p.m.
Hemophilia and Coagulopathy
Philip Kuriakose, MD, Henry Ford Cancer Institute
3:00 p.m.
Panel Discussion
3:30 p.m.
Closing Remarks and Program Adjournment
back to top